12
12
10
10
5
5
15
15
28
28
52
52
25
25
11
11
2
2
1
1
2019
2009
Company (175)University (13)Hospital (2)
1 - 10 of 175
Sort by
Patent
Publication NumberBR PI1011709 A2Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2010-06-03Publication Date2019-09-24
Patent
Publication NumberEP 2438169 B1Filing StatusIssued PatentAvailabilityUnknownFiling Date2010-06-03Publication Date2017-08-09
Patent
Publication NumberCY 1115493 T1Filing StatusOtherAvailabilityUnknownFiling Date2014-08-20Publication Date2017-01-04
Η εφεύρεση παρέχει βελτιωμένους συνδέτες νουκλεϊκών οξέων που παρεμποδίζουν την πήξη και βελτιωμένους ρυθμιστές των νουκλεϊκών οξέων για την παροχή ιδανικών ρυθμιστών της πήξης. Τα εν λόγω βελτιωμένα νουκλεϊκά οξέα οξέα και οι εν λόγω ρυθμιστές είναι ιδιαίτερα χρήσιμοι για την παρεμπόδιση της πήξης σε ένα ξενιστή που υποβάλλεται σε σχέδιο θεραπείας όπως εγχείρηση ή αορτοστεφανιαία παράκαμψη.
SEC Filing
Accession Number0001193125-16-754602Form Type8-KAcceptance Date2016-11-01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuantto Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2016 Tobira Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35953 03-0422069 (State or other Jurisdiction of Incorporation) (Commission File No.) (IRS Employer Identification No.) 701 Gateway Blvd, Suite 300 Sout…
SEC Filing
Accession Number0001193125-16-714192Form Type8-KAcceptance Date2016-09-20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuantto Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2016 Tobira Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35953 03-0422069 (State or other Jurisdiction of Incorporation) (Commission File No.) (IRS Employer Identification No.) 701 Gateway Blvd, Suite 300 So…
SEC Filing
Accession Number0001193125-16-706579Form Type10-QAcceptance Date2016-09-09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 2) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35953 TOBIRA THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its C…
SEC Filing
Accession Number0001564590-16-023662Form Type8-KAcceptance Date2016-08-09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2016 Tobira Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35953 03-0422069 (State or other Jurisdiction of Incorporation) (Commission File No.) (IRS Employer Identification No.) 701 Gateway Blvd, Suite 300 South San…
SEC Filing
Accession Number0001564590-16-023667Form Type10-QAcceptance Date2016-08-09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35953 TOBIRA THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its Charte…
SEC Filing
Accession Number0001564590-16-021407Form Type8-KAcceptance Date2016-07-25
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2016 Tobira Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35953 03-0422069 (State or other Jurisdiction of Incorporation) (Commission File No.) (IRS Employer Identification No.) 701 Gateway Blvd, Suite 300 South San…
SEC Filing
Accession Number0001564590-16-018569Form Type8-KAcceptance Date2016-05-09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2016 Tobira Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35953 03-0422069 (State or other Jurisdiction of Incorporation) (Commission File No.) (IRS Employer Identification No.) 701 Gateway Blvd, Suite 300 South San Fr…
We found 175 documents that match your Search
Research Grants: 1
Patents: 88
Clinical Trials: 22
SEC Filings: 64

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in